Literature DB >> 15019701

The diagnosis of mitochondrial muscle disease.

Robert W Taylor1, Andrew M Schaefer, Martin J Barron, Robert McFarland, Douglass M Turnbull.   

Abstract

Mitochondrial respiratory chain abnormalities are an important cause of neuromuscular disease and may be due to defects of either the mitochondrial or nuclear genome. On account of the clinical and genetic heterogeneity exhibited by the mitochondrial myopathies, their investigation and diagnosis remains a challenge, requiring a combination of techniques including muscle histochemistry, biochemical assessment of respiratory chain function and molecular genetic studies. Here, we describe a step-by-step approach to the clinical and laboratory diagnosis of mitochondrial muscle disease, highlighting the many potential problems that can hinder reaching the correct diagnosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15019701     DOI: 10.1016/j.nmd.2003.12.004

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  56 in total

1.  Some physicochemical properties of hemoglobin-manitoba (alpha2 102Ser replaced by Arg (G9) beta2).

Authors:  R N Wrightstone; L L Smith; J B Wilson; F Vella; T H Huisman
Journal:  Biochim Biophys Acta       Date:  1975-12-15

2.  [Kearns-Sayre syndrome : a mitochondrial disease (OMIM #530000)].

Authors:  W J Mayer; M Remy; G Rudolph
Journal:  Ophthalmologe       Date:  2011-05       Impact factor: 1.059

3.  Autism in the Son of a Woman with Mitochondrial Myopathy and Dysautonomia: A Case Report.

Authors:  Bradley D Brown; Theodore Rais
Journal:  Innov Clin Neurosci       Date:  2015 Sep-Oct

Review 4.  [Lipid lowering drug and other toxic myopathies].

Authors:  B G H Schoser; D Pongratz
Journal:  Internist (Berl)       Date:  2005-11       Impact factor: 0.743

Review 5.  Mitochondrial DNA mutations in human disease.

Authors:  Robert W Taylor; Doug M Turnbull
Journal:  Nat Rev Genet       Date:  2005-05       Impact factor: 53.242

6.  The role of neutrophil extracellular traps and TLR signaling in skeletal muscle ischemia reperfusion injury.

Authors:  Nicole J Edwards; Charles Hwang; Simone Marini; Chase A Pagani; Philip J Spreadborough; Cassie J Rowe; Pauline Yu; Annie Mei; Noelle Visser; Shuli Li; Geoffrey E Hespe; Amanda K Huber; Amy L Strong; Miriam A Shelef; Jason S Knight; Thomas A Davis; Benjamin Levi
Journal:  FASEB J       Date:  2020-10-22       Impact factor: 5.191

7.  Oxidized proportion of muscle coenzyme Q10 increases with age in healthy children.

Authors:  Petra Niklowitz; Jürgen Scherer; Frank Döring; Michael Paulussen; Thomas Menke
Journal:  Pediatr Res       Date:  2015-06-24       Impact factor: 3.756

Review 8.  Muscle biopsy.

Authors:  G Meola; E Bugiardini; R Cardani
Journal:  J Neurol       Date:  2011-07-30       Impact factor: 4.849

9.  Isolated cytochrome c oxidase deficiency as a cause of MELAS.

Authors:  Walter Rossmanith; Michael Freilinger; Julia Roka; Thomas Raffelsberger; Karin Moser-Their; Daniela Prayer; Günther Bernert; Reginald Bittner
Journal:  BMJ Case Rep       Date:  2009-01-23

10.  Muscle-specific AMPK β1β2-null mice display a myopathy due to loss of capillary density in nonpostural muscles.

Authors:  Melissa M Thomas; David C Wang; Donna M D'Souza; Matthew P Krause; Andrew S Layne; David S Criswell; Hayley M O'Neill; Michael K Connor; Judy E Anderson; Bruce E Kemp; Gregory R Steinberg; Thomas J Hawke
Journal:  FASEB J       Date:  2014-02-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.